Centre Hospitalier Intercom Gregoire
- Address
- 56 Boulevard De La Boissiere, 93100 Montreuil, France
Centre Hospitalier Intercom Gregoire - Advanced Critical Care and Specialty Medicine Research
Centre Hospitalier Intercom Gregoire is a distinguished medical research institution specializing in critical care medicine and complex therapeutic interventions. The center demonstrates particular expertise in intensive care unit (ICU) management and antimicrobial stewardship, addressing urgent challenges in infectious disease treatment and antibiotic resistance. Their research portfolio encompasses emergency cardiac care and specialized nephrology, reflecting a comprehensive approach to acute and chronic medical conditions.
- Antibiotic resistance and carbapenem-sparing strategies for ESBL-producing Enterobacteriaceae infections in ICU settings
- Emergency cardiovascular interventions and acute STEMI management in pre-hospital settings
- Renal immunology and innovative treatments for Minimal Change Nephrotic Syndrome
The center's research demonstrates a commitment to developing evidence-based alternatives to traditional treatments, particularly in combating antimicrobial resistance through novel antibiotic protocols. Their work in acute myocardial infarction explores cutting-edge pharmacological interventions delivered in emergency settings, while their nephrology program investigates immunomodulatory therapies like Rituximab for preventing disease relapse. This multidisciplinary approach positions the center at the forefront of translating clinical research into improved patient outcomes across critical care, cardiology, and nephrology specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 11 of 12 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Intercom Gregoire
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of 7-Day Oral Doxycycline for Asymptomatic Anal Lymphogranuloma Venereum Infection: Multicentre Study | Centre Hospitalier Universitaire De Bordeaux | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2021-01-27 | 2021-01-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.